Vertex Pharmaceuticals recently reported positive clinical trial data for povetacicept in IgA nephropathy and primary membranous nephropathy, showing significant proteinuria reduction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback